Crypto Data Space Teknoloji ve Medya Anonim Åžirketi2d
Novo Stock: Analyst Predicts 24% Gain After Stock Drop
Novo Stock- Kepler Cheuvreux’s analyst upgrades Novo Nordisk to ‘buy,’ predicting a 24% gain after a 50% drop from its peak.
Why This Long-Time Skeptic Finally Upgraded Novo Nordisk (NVO) to Buy
Novo Nordisk (NVO), the company behind popular diabetes and obesity treatments Ozempic and Wegovy, saw its stock rise on Thursday after ...
Novo Nordisk rebounds as Kepler upgrades Ozempic maker at long last
Novo Nordisk (NVO) stock rebounds after Kepler Cheuvreux upgrades to Buy following a 42% stock drop over the past year. Read ...
Saab downgraded to Reduce from Hold at Kepler Cheuvreux
Kepler Cheuvreux analyst Aymeric Poulain downgraded Saab (SAABF) to Reduce from Hold with a price target of SEK 275, up from SEK 245. The ...
Kepler Capital Remains a Buy on Telecom Italia SPA (0H6I)
Detailed price information for Telecom Italia S.P.A. (TIIAY) from The Globe and Mail including charting and trades.
Independent.ie on MSN6d
Novo Nordisk shares plunge after obesity drug trial
Novo Nordisk’s share price plunged the most since December after another disappointment for the drugmaker’s next-generation shot CagriSema. The medicine helped patients with diabetes lose 15.7pc of ...